vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

WIDEPOINT CORP is the larger business by last-quarter revenue ($42.3M vs $31.1M, roughly 1.4× LIFECORE BIOMEDICAL, INC. \DE\). WIDEPOINT CORP runs the higher net margin — -2.0% vs -32.1%, a 30.1% gap on every dollar of revenue. On growth, WIDEPOINT CORP posted the faster year-over-year revenue change (12.3% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-270.0K). Over the past eight quarters, WIDEPOINT CORP's revenue compounded faster (11.2% CAGR vs -0.1%).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

LFCR vs WYY — Head-to-Head

Bigger by revenue
WYY
WYY
1.4× larger
WYY
$42.3M
$31.1M
LFCR
Growing faster (revenue YoY)
WYY
WYY
+16.7% gap
WYY
12.3%
-4.5%
LFCR
Higher net margin
WYY
WYY
30.1% more per $
WYY
-2.0%
-32.1%
LFCR
More free cash flow
LFCR
LFCR
$295.0K more FCF
LFCR
$25.0K
$-270.0K
WYY
Faster 2-yr revenue CAGR
WYY
WYY
Annualised
WYY
11.2%
-0.1%
LFCR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
LFCR
LFCR
WYY
WYY
Revenue
$31.1M
$42.3M
Net Profit
$-10.0M
$-849.4K
Gross Margin
25.0%
13.8%
Operating Margin
-9.9%
-1.9%
Net Margin
-32.1%
-2.0%
Revenue YoY
-4.5%
12.3%
Net Profit YoY
-52.0%
-138.3%
EPS (diluted)
$-0.29
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
WYY
WYY
Q4 25
$42.3M
Q3 25
$31.1M
$36.1M
Q2 25
$37.9M
Q1 25
$35.2M
$34.2M
Q4 24
$32.6M
$37.7M
Q3 24
$24.7M
$34.6M
Q2 24
$36.0M
Q1 24
$35.7M
$34.2M
Net Profit
LFCR
LFCR
WYY
WYY
Q4 25
$-849.4K
Q3 25
$-10.0M
$-559.2K
Q2 25
$-618.5K
Q1 25
$-14.8M
$-724.1K
Q4 24
$-6.6M
$-356.4K
Q3 24
$-16.2M
$-425.2K
Q2 24
$-499.6K
Q1 24
$15.6M
$-653.1K
Gross Margin
LFCR
LFCR
WYY
WYY
Q4 25
13.8%
Q3 25
25.0%
14.6%
Q2 25
13.5%
Q1 25
28.0%
14.0%
Q4 24
34.0%
12.6%
Q3 24
21.8%
13.6%
Q2 24
13.6%
Q1 24
33.3%
13.6%
Operating Margin
LFCR
LFCR
WYY
WYY
Q4 25
-1.9%
Q3 25
-9.9%
-1.3%
Q2 25
-1.9%
Q1 25
-25.7%
-2.4%
Q4 24
-6.0%
-0.8%
Q3 24
-46.9%
-1.3%
Q2 24
-1.3%
Q1 24
-2.5%
-1.9%
Net Margin
LFCR
LFCR
WYY
WYY
Q4 25
-2.0%
Q3 25
-32.1%
-1.5%
Q2 25
-1.6%
Q1 25
-42.0%
-2.1%
Q4 24
-20.2%
-0.9%
Q3 24
-65.7%
-1.2%
Q2 24
-1.4%
Q1 24
43.8%
-1.9%
EPS (diluted)
LFCR
LFCR
WYY
WYY
Q4 25
$-0.08
Q3 25
$-0.29
$-0.06
Q2 25
$-0.06
Q1 25
$-0.47
$-0.08
Q4 24
$-0.25
$-0.05
Q3 24
$-0.53
$-0.04
Q2 24
$-0.05
Q1 24
$0.42
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$18.9M
$9.8M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
$11.5M
Total Assets
$235.2M
$79.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
WYY
WYY
Q4 25
$9.8M
Q3 25
$18.9M
$12.1M
Q2 25
$6.8M
Q1 25
$5.4M
$3.7M
Q4 24
$9.5M
$6.8M
Q3 24
Q2 24
Q1 24
Total Debt
LFCR
LFCR
WYY
WYY
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
LFCR
LFCR
WYY
WYY
Q4 25
$11.5M
Q3 25
$-10.5M
$12.2M
Q2 25
$12.6M
Q1 25
$2.2M
$13.0M
Q4 24
$15.4M
$13.6M
Q3 24
$-3.9M
$13.8M
Q2 24
$14.0M
Q1 24
$17.7M
$14.2M
Total Assets
LFCR
LFCR
WYY
WYY
Q4 25
$79.8M
Q3 25
$235.2M
$70.6M
Q2 25
$76.6M
Q1 25
$237.7M
$71.4M
Q4 24
$255.4M
$71.6M
Q3 24
$246.8M
$56.9M
Q2 24
$58.6M
Q1 24
$246.2M
$54.4M
Debt / Equity
LFCR
LFCR
WYY
WYY
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
WYY
WYY
Operating Cash FlowLast quarter
$1.8M
$-173.5K
Free Cash FlowOCF − Capex
$25.0K
$-270.0K
FCF MarginFCF / Revenue
0.1%
-0.6%
Capex IntensityCapex / Revenue
5.6%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
WYY
WYY
Q4 25
$-173.5K
Q3 25
$1.8M
$5.9M
Q2 25
$3.2M
Q1 25
$1.2M
$-3.2M
Q4 24
$-6.1M
$2.4M
Q3 24
$-613.0K
$1.9M
Q2 24
$-1.1M
Q1 24
$-1.4M
$-1.6M
Free Cash Flow
LFCR
LFCR
WYY
WYY
Q4 25
$-270.0K
Q3 25
$25.0K
$5.9M
Q2 25
$3.1M
Q1 25
$-4.3M
$-3.3M
Q4 24
$-8.6M
$2.4M
Q3 24
$-4.0M
$1.8M
Q2 24
$-1.1M
Q1 24
$-7.8M
$-1.6M
FCF Margin
LFCR
LFCR
WYY
WYY
Q4 25
-0.6%
Q3 25
0.1%
16.4%
Q2 25
8.1%
Q1 25
-12.1%
-9.5%
Q4 24
-26.3%
6.4%
Q3 24
-16.3%
5.3%
Q2 24
-3.0%
Q1 24
-21.8%
-4.6%
Capex Intensity
LFCR
LFCR
WYY
WYY
Q4 25
0.2%
Q3 25
5.6%
0.1%
Q2 25
0.2%
Q1 25
15.5%
0.1%
Q4 24
7.5%
0.1%
Q3 24
13.9%
0.2%
Q2 24
0.0%
Q1 24
17.8%
0.0%
Cash Conversion
LFCR
LFCR
WYY
WYY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons